Picture of OWC Pharmaceutical Research logo

OWCP OWC Pharmaceutical Research Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-3.44%
3m-3.21%
6m-7.3%
1yr-21.96%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-99%
50d MA-79.84%
200d MA-97.03%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-306.3%
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201931st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2019 / 2020

Blurred out image of OWC Pharmaceutical Research EPS forecast chart

Profile Summary

OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company's Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.

Directors

Last Annual
December 31st, 2018
Last Interim
September 30th, 2019
Incorporated
March 6th, 2008
Public Since
August 20th, 2008
No. of Shareholders
100
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
497,498,338
Blurred out image of a map
Address
2 Ben Gurion St., RAMAT GAN, 5257334
Web
Phone
+972 39191921
Auditors
Fahn, Kanne & Co.

OWCP Share Price Performance

Similar to OWCP

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of ACCUSTEM SCIENCES logo

ACCUSTEM SCIENCES

us flag iconPink Sheets on Nasdaq

Picture of Acutus Medical logo

Acutus Medical

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ